Chemoinformaics analysis of Delta-Amino-Levulinic-Acid
Molecular Weight | 275.497 | nRot | 7 |
Heavy Atom Molecular Weight | 250.297 | nRig | 2 |
Exact Molecular Weight | 275.137 | nRing | 0 |
Solubility: LogS | -3.149 | nHRing | 0 |
Solubility: LogP | 2.387 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 49.6058 |
nHD | 1 | BPOL | 60.0022 |
QED | 0.723 |
Synth | 3.248 |
Natural Product Likeliness | 0.055 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.011 |
Pgp-sub | 0.095 |
HIA | 0.948 |
CACO-2 | -5.403 |
MDCK | 0.000247118 |
BBB | 0.022 |
PPB | 0.879477 |
VDSS | 1.054 |
FU | 0.144851 |
CYP1A2-inh | 0.112 |
CYP1A2-sub | 0.951 |
CYP2c19-inh | 0.042 |
CYP2c19-sub | 0.198 |
CYP2c9-inh | 0.008 |
CYP2c9-sub | 0.548 |
CYP2d6-inh | 0.058 |
CYP2d6-sub | 0.626 |
CYP3a4-inh | 0.019 |
CYP3a4-sub | 0.152 |
CL | 3.387 |
T12 | 0.939 |
hERG | 0.009 |
Ames | 0.023 |
ROA | 0.004 |
SkinSen | 0.903 |
Carcinogencity | 0.093 |
EI | 0.528 |
Respiratory | 0.966 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.654042 |